J Pain Palliat Care Pharmacother. 2016 Jun;30(2):141-5. doi: 10.3109/15360288.2016.1173762.
On March 22, 2016, the Food and Drug Administration (FDA) announced enhanced warnings for immediate-release opioid pain medications related to risks of misuse, abuse, addiction, overdose, and death. The new safety warnings also added to all prescription opioid medications to inform prescribers and patients of additional risks related to opioid use.
2016年3月22日,美国食品药品监督管理局(FDA)宣布加强对速释型阿片类镇痛药的警示,这些药物存在滥用、成瘾、过量使用及致死风险。新的安全警示还添加到所有处方阿片类药物上,以告知开处方的医生和患者与使用阿片类药物相关的其他风险。